Research lacking on drugs for older children with autism, study finds

September 24, 2012 by Serena Gordon, Healthday Reporter
Research lacking on drugs for older children with autism, study finds
Majority seem to be 'taking medications we have very little evidence for,' doctor says.

(HealthDay)—More and more children are growing up with autism, and although many treatments and interventions are now available, clinical studies on the use of medications in teens and young adults are lacking, according to new research.

"The majority of (older) individuals with spectrum disorders appear to be taking medications that we have very little evidence for," said the study's lead author, Dr. Jeremy Veenstra-VanderWeele, director of the Treatment and Research Institute for Autism Spectrum Disorders at the Vanderbilt Brain Institute in Nashville, Tenn.

"In the absence of sufficient evidence, parents and people with autism should find a clinician who tells you what's known and unknown about the potential benefits and risks of any medication," he said. "It should be a shared decision-making process."

Results of the study were published online on Sept. 24 in the journal Pediatrics.

Autism spectrum disorders are that impair social development and communication. Autism spectrum disorders also may cause and even self-abusive behavior, such as head banging, according to the U.S. National Institute of Neurological Disorders and Stroke (NINDS).

It is estimated that about one in 88 American children has been identified with an autism spectrum disorder

As children with autism age, some do experience significant improvements, according to NINDS, but many do not. There is no cure for autism, although there are many treatments available, including education and and medications.

Medications usually are used to treat some of the symptoms associated with autism, rather than the core symptoms of the condition, according to background information in the new study. For example, the medication risperidone (brand name Risperdal) may be used to treat behavioral symptoms associated with autism, such as aggression, outbursts and irritability, said Dr. Melissa Nishawala, medical director of the Clinical and Research Program at the NYU Child Study Center in New York City.

"Medications like risperidone and aripiprazole don't address the cause of autism, but they help calm down [people with autism]," Veenstra-VanderWeele said.

For the new study, the researchers reviewed medical literature from 1980 through 2011 to find clinical trials on drugs for people with autism between the ages of 13 and 30 years old. They found eight studies with at least 20 participants. Two investigators independently assessed the quality of the studies.

The researchers said they found four studies of fair quality while the other four were poor. The studies included reviews of antipsychotic medications, such as risperidone and haloperidol (Haldol); serotonin reuptake inhibitors, such as fluvoxamine (Luvox) and clomipramine (Anafranil); and opioid receptor agonists, such as naltrexone (Depade).

The researchers felt that, overall, there wasn't enough data on medications in the teen and young adult autism population. Risperidone wasn't well studied in teens and young adults, but there was evidence for its use if the entire pediatric population was considered, the study said.

Although behavioral and educational interventions weren't included in the new study, Veenstra-VanderWeele said he suspects there's a lack of evidence for these types of treatments in older children and young adults too.

"We really don't know if intensive behavior interventions continue to benefit individuals as they get older," he said.

NYU's Nishawala said: "The most important thing for parents to take away is that we know there are a few medications that have been studied that can help. Certain symptoms like irritability, agitation and aggression can be controlled with medications, but there's lesser evidence that repetitive behaviors can be treated."

Nishawala added that although she and others who treat older children and with autism would love to have more evidence-based research on the medications they use, it can be difficult to get parents and to participate in clinical trials when medications are already available to them for what's known as "off-label" use. That's when doctors prescribe medications for a condition for which the drug has yet to receive U.S. Food and Drug Administration approval.

In addition, she said, it's difficult to get funding for trials, particularly when a drug already has been approved.

Explore further: Little evidence supports autism treatment options in adolescents

More information: Learn more about autism and teens from the Nemours Foundation.

Related Stories

Little evidence supports autism treatment options in adolescents

August 27, 2012
Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.

Repetitive behaviors in adults with Autism Spectrum disorders significantly lessen with antidepressant treatment

December 5, 2011
(Medical Xpress) -- Restricted, repetitive behavior, such as compulsive arranging and rigid adherence to routines, is a defining symptom of autism spectrum disorders.

New clinical trial to examine medication to treat social withdrawal in Fragile X and autism

July 20, 2011
Children and adults with social withdrawal due to Fragile X syndrome, the most common cause of inherited intellectual disability and the most common known single gene cause of autism, may benefit from an experimental drug ...

Recommended for you

Nearly imperceptible fluctuations in movement correspond to autism diagnoses

January 17, 2018
A new study led by researchers at Indiana University and Rutgers University provides the strongest evidence yet that nearly imperceptible changes in how people move can be used to diagnose neurodevelopmental disorders, including ...

Epigenetics study helps focus search for autism risk factors

January 16, 2018
Scientists have long tried to pin down the causes of autism spectrum disorder. Recent studies have expanded the search for genetic links from identifying genes toward epigenetics, the study of factors that control gene expression ...

Being bilingual may help autistic children

January 16, 2018
Children with Autism Spectrum Disorders (ASD) often have a hard time switching gears from one task to another. But being bilingual may actually make it a bit easier for them to do so, according to a new study which was recently ...

No rise in autism in US in past three years: study

January 2, 2018
After more than a decade of steady increases in the rate of children diagnosed with autism in the United States, the rate has plateaued in the past three years, researchers said Tuesday.

Autism therapy: Brain stimulation restores social behavior in mice

December 13, 2017
Scientists are examining the feasibility of treating autistic children with neuromodulation after a new study showed social impairments can be corrected by brain stimulation.

Social phobia linked to autism and schizophrenia

December 11, 2017
New Swinburne research shows that people who find social situations difficult tend to have similar brain responses to those with schizophrenia or autism.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.